Inventor · disambiguated record
Joseph Weinstock
Also filed as: WEINSTOCK JOSEPH
65 granted patents·7 pending applications·828 citations·filing 1973–2018
99Inventor score
Files withSMITHKLINE BEECHAM CORP24SMITHKLINE CORP21SMITHKLINE BECKMAN CORP14PROGENRA INC3FINKELSTEIN JOSEPH A2
Top patents by PatentIndex Score
72 records- 0197US4359464A3-Furylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines and antihypertensive use thereofSMITHKLINE BECKMAN CORP·Filed 1981·Granted Nov 16, 1982·53 cites·7 claims
- 0296US4197297A6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepinesSMITHKLINE CORP·Filed 1978·Granted Apr 8, 1980·33 cites·18 claims
- 0394US4251525A3-Allyl-7,8-dihydroxy-6-halo-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivativesSMITHKLINE CORP·Filed 1979·Granted Feb 17, 1981·48 cites·7 claims
- 0492US5185351AImidazolyl-alkenoic acids useful as angiotensin II receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 1991·Granted Feb 9, 1993·119 cites·42 claims
- 0592US4160765AMethod for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compoundsSMITHKLINE CORP·Filed 1976·Granted Jul 10, 1979·39 cites·1 claims
- 0690US9717717B1Methods of treating cancer through the inhibition of USP7 and immune system modulationPROGENRA INC·Filed 2016·Granted Aug 1, 2017·9 cites·18 claims
- 0789US4554284A7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-onesSMITHKLINE BECKMAN CORP·Filed 1984·Granted Nov 19, 1985·33 cites·14 claims
- 0886US5312828ASubstituted imidazoles having angiotensin II receptor blocking activityFINKELSTEIN JOSEPH A·Filed 1991·Granted May 17, 1994·37 cites·24 claims
- 0985US5444081ASubstituted histidines having angiotension II receptor antagonist activitySMITHKLINE BEECHAM CORP·Filed 1991·Granted Aug 22, 1995·54 cites·11 claims
- 1084US4104379ASubstituted 1-alkylthiophenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compoundsSMITHKLINE CORP·Filed 1977·Granted Aug 1, 1978·21 cites·16 claims
- 1183US8680139B2Anti-neoplastic compounds, compositions and methodsCAO PING·Filed 2010·Granted Mar 25, 2014·10 cites·12 claims
- 1281US6653347B2IL-8 receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Nov 25, 2003·15 cites·5 claims
- 1379US6559179B1Fatty acid synthase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2000·Granted May 6, 2003·14 cites·4 claims
- 1478US6498187B1Fatty acid synthase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Dec 24, 2002·12 cites·4 claims
- 1578US5234917ASubstituted 5-(alkyl)carboxamide imidazolesFINKELSTEIN JOSEPH A·Filed 1990·Granted Aug 10, 1993·23 cites·20 claims
- 1675US5418250AImidazolyl-alkenoic acids useful as angiotensin II receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 1993·Granted May 23, 1995·14 cites·7 claims
- 1775US4265889A6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepinesSMITHKLINE CORP·Filed 1978·Granted May 5, 1981·7 cites·11 claims
- 1875US4192872A6-Halo-3-lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepinesSMITHKLINE CORP·Filed 1978·Granted Mar 11, 1980·5 cites·14 claims
- 1974US3931207ATetramic acid analogs of pulvinic acidSMITHKLINE CORP·Filed 1973·Granted Jan 6, 1976·8 cites·7 claims
- 2073US6458845B1Macrophage scavenger receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 2000·Granted Oct 1, 2002·8 cites·5 claims
- 2172US3962438AAnti-arthritic 1H-pyrimido-(5,4,3-kl)phenothiazine-1,3(2H)-diones and 1-thionesSMITHKLINE CORP·Filed 1975·Granted Jun 8, 1976·7 cites·12 claims
- 2271US6210900B1Method of encoding a series of combinatorial libraries and developing structure activity relationshipsSMITHKLINE BEECHAM CORP·Filed 1995·Granted Apr 3, 2001·35 cites·4 claims
- 2371US5294631ASubstituted benzimidazoles useful as angiotension II receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 1991·Granted Mar 15, 1994·29 cites·20 claims
- 2471US5248689ASubstituted N-(imidazolyl)alkyl alanine derivativesSMITHKLINE BEECHAM CORP·Filed 1990·Granted Sep 28, 1993·13 cites·20 claims
- 2570US4171359ABenz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepinesSMITHKLINE CORP·Filed 1978·Granted Oct 16, 1979·9 cites·16 claims
- 2669US4255445A8-Hydroxy-6,7-(2-methyl-2,3-dihydrofuro)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepinesSMITHKLINE CORP·Filed 1980·Granted Mar 10, 1981·6 cites·9 claims
- 2768US5656650AAngiotensin II receptor blocking compositionsSMITHKLINE BEECHAM CORP·Filed 1995·Granted Aug 12, 1997·33 cites·20 claims
- 2866US4600714AFenoldopam 4',8-bis-hydrogen sulfate and dopaminergic use thereofSMITHKLINE BECKMAN CORP·Filed 1984·Granted Jul 15, 1986·9 cites·7 claims
- 2965US4861771ACarbamates of 6-chloro-7,8-dihydroxy-1-(4'-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine as prodrugsSMITHKLINE BECKMAN CORP·Filed 1989·Granted Aug 29, 1989·14 cites·16 claims
- 3063US5177096ASubstituted 5-((tetrazolyl)alkenyl)imidazoles and pharmaceutical methods of use thereofSMITHKLINE BEECHAM CORP·Filed 1990·Granted Jan 5, 1993·8 cites·16 claims
- 3163US4769368A2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepinesSMITHKLINE BECKMAN CORP·Filed 1986·Granted Sep 6, 1988·11 cites·8 claims
- 3262US3984559ACompositions comprising tetramic acid analogs of pulvinic acid and methods of combating arthritisSMITHKLINE CORP·Filed 1975·Granted Oct 5, 1976·4 cites·11 claims
- 3361US6620826B2Endothelin receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Sep 16, 2003·1 cites·9 claims
- 3461US6255298B1Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseasesSMITHKLINE BEECHAM CORP·Filed 1998·Granted Jul 3, 2001·18 cites·10 claims
- 3560US5395847AImidazolyl-alkenoic acidsSMITHKLINE BEECHAM CORP·Filed 1994·Granted Mar 7, 1995·6 cites·11 claims
- 3658US5565577AProcess for preparing 1-alkyaryl-2-alkyl-5-formylimidazoleSMITHKLINE BEECHAM CORP·Filed 1993·Granted Oct 15, 1996·8 cites·11 claims
- 3758US4593106A4-[2-(dialkylamino)ethyl]-7-hydroxyisatinsSMITHKLINE BECKMAN CORP·Filed 1984·Granted Jun 3, 1986·3 cites·2 claims
- 3858US4165372A6-Carboxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds and use as dopaminergic agentsSMITHKLINE CORP·Filed 1977·Granted Aug 21, 1979·3 cites·15 claims
- 3955US4405787A3-Carboxy-2-azabicyclo[2.2.1]heptane derivativesSMITHKLINE BECKMAN CORP·Filed 1982·Granted Sep 20, 1983·3 cites·10 claims
- 4055US4327023AIntermediates for preparing 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepinesSMITHKLINE CORP·Filed 1980·Granted Apr 27, 1982·3 cites·4 claims
- 4153US5447949AN-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activitySMITHKLINE BEECHAM CORP·Filed 1992·Granted Sep 5, 1995·4 cites·10 claims
- 4253US5444080ASubstituted [1H-imidazol-5-ylialkanoic acids having angiotension II receptor antagonist activitySMITHKLINE BEECHAM CORP·Filed 1991·Granted Aug 22, 1995·10 cites·10 claims
- 4351US4352754A3-Thienylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepinesSMITHKLINE CORP·Filed 1980·Granted Oct 5, 1982·3 cites·5 claims
- 4450US11273154B2Azole compounds as ubiquitin-specific protease USP7 inhibitorsPROGENRA INC·Filed 2018·Granted Mar 15, 2022·0 cites·10 claims
- 4550US5728842ASubstituted imidazolyl-alkylthio-alkanoic acidsSMITHKLINE BEECHAM CORP·Filed 1993·Granted Mar 17, 1998·3 cites·5 claims
- 4649US5929249ASubstituted imidazolyl-alkyethio-aldanoic acidsSMITHKLINE BEECHAM CORP·Filed 1998·Granted Jul 27, 1999·8 cites·12 claims
- 4748US9072749B2Treatment of age-related macular degenerationWEINSTOCK JOSEPH·Filed 2009·Granted Jul 7, 2015·0 cites·7 claims
- 4847US2003004202A1Endothelin receptor antagonistsSMITHKLINE BEECHAM CORP·Filed 2002·Application pending·0 cites
- 4946US4321195A6-Halo-7,8-dimethoxy-1-(methoxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepinesSMITHKLINE CORP·Filed 1979·Granted Mar 23, 1982·1 cites·6 claims
- 5045US10292973B2Covalent irreversible inhibitors of USP7 as anti-cancer agentsPROGENRA INC·Filed 2016·Granted May 21, 2019·0 cites·27 claims
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joseph Weinstock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →